Boston
Reify Health is a developer of solutions for faster, predictable, and more accessible clinical trials, providing clinical optimization software, with a focus on effective enrollment, and transformative clinical trial infrastructure that delivers research directly to more healthcare providers, communities, and patients wherever they are.
Estimated valuation today
$166M
-96.53% since last round
Calculated based on estimated multiplier and revenue.
Estimated multiplier for Reify Health
2.46x revenue
Calculated based on public comps and hype multiple.
Revenue
Update this based on your knowledge or projections. Calculations use last 12 months revenue.
Hype Multiple
Currently selected comps have a median growth rate of 11.40%
This premium represents how much of a bonus the company receives on its valuation for its additional growth compared to the selected public comps. The valuation is multipled by the Hype Multiple to get the final valuation. You can read more about this from a16z.
multiple
In an event of a merger or aquisition, the investors will get their money back first. In this case, the investors got paid out first and there is no money left which means employee common stock is worthless.
The last round was 4 months ago.
Date
April 2022
Valuation
$4.8B
Amount raised
$231M
We estimate company valuation by comparing it to similiar companies in the public market. The revenue multipler is calculated by taking a company's current valuation and dividing it by its total revenue.
Multiple at last round
1.62x revenue
Today's multiple
1.64x revenue
Change
1.30%
Companies
Industry – Healthcare
Last updated 5 mins ago.
| Remove | Name | Ticker | Price multiple |
|---|---|---|---|
| Reify Health | 1.64x | ||
| 1Life Healthcare Inc | ONEM | 4.38x | |
| HCA Holdings Inc | HCA | 1.04x | |
| Tenet Healthcare Corporation | THC | 0.37x | |
| Quest Diagnostics Incorporated | DGX | 1.51x | |
| Humana Inc | HUM | 0.67x |
| Date | Round | Amount raised | Price per share (Preferred) | Valuation |
|---|---|---|---|---|
| Apr 2022 | Series D | $230.78MM | $11.11 | $4.78B |
| Aug 2021 | Series C | $220MM | $5.36 | $2.12B |
| Aug 2020 | Series B | $30MM | $0.48 | $154.14MM |
| Dec 2018 | Series A | $7.4MM | $0.12 | $27.6MM |
| Feb 2013 | Series Seed | $2.02MM | $0.04 | $5.77MM |
With a revenue of $67M and a Hype Multiple of 1.5x,
Reify Health is estimated to be worth $166M.